Cryptome CEO resigns

By Melissa Trudinger
Tuesday, 19 October, 2004

Cryptome Pharmaceuticals (ASX: CRP) has announced that CEO Jeffrey Travis has resigned for personal reasons.

US expatriate Travis, who was appointed in January shortly after the company floated on the ASX, is expected to return to the US. The company plans to appoint an interim CEO in the near future.

New route into cells found for gene therapy viruses

Scientists have identified a previously unknown gateway into human cells — a receptor...

Link between oestrogen and heart health found in women

Scientists found that oestrogen helps increase the ANXA1 protein, and when ANXA1 is missing, the...

Frequent nightmares accelerate aging, increase risk of death

Nghtmares independently predict faster biological aging and earlier mortality — even after...

Content from other channels on our network

A sweet solution: Swisslog automates confectionery handling for Mondelēz

Jack Link's APAC buys beef stick brand KOOEE! Snack Foods

Automation system designed to guide bottles without breakage

Graph-Pak solutions on show at CeMAT

Post-harvest tech to extend storage life of mangoes

National Nursing Forum commences with over 800 delegates

Where to from here? A sustainable path for day hospitals

Spacers for pressurised metered-dose inhalers — resources released

Victorian Medical Equipment Replacement Program funds 10 projects

Chronic pain, care and communication: a lived experience perspective

New tool gives makes training a robot more intuitive

CSIRO launches National Energy Analysis Centre

Wastewater contaminants can boost hydrogen production: research

Transgrid finalises system strength plan

CSIRO spin-off targets future health ingredients with precision fermentation